Last 12 months
Inside the activity.
19 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 18 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2023 Filed Feb 3, 2023 21:13 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Stock | 121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002473 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,616 F1 · kind: On January 31, 2023 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On January 31, 2023 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 21:13 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002473 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 31, 2023 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 30, 2022 Filed Dec 3, 2022 00:09 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028356 · rdgdoc.xml · derivative · entry 3 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549 Underlying: Common Stock · 183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 30, 2022 Filed Dec 3, 2022 00:09 UTC |
Hollingsworth Jane HDirector
|
Disposition to issuerCommon Stock | 68 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-028356 · rdgdoc.xml · nonDerivative · entry 2 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,001 F1 · kind: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 30, 2022 Filed Dec 3, 2022 00:09 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionCommon Stock | 183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-028356 · rdgdoc.xml · nonDerivative · entry 1 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On November 30, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $442.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.50. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:15 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-025572 · rdgdoc.xml · derivative · entry 3 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:15 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Stock | 121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-025572 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410 F1 · kind: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:15 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-025572 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| August 31, 2022 Filed Sep 3, 2022 01:06 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021841 · rdgdoc.xml · derivative · entry 3 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732 Underlying: Common Stock · 183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| August 31, 2022 Filed Sep 3, 2022 01:06 UTC |
Hollingsworth Jane HDirector
|
Disposition to issuerCommon Stock | 67 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-021841 · rdgdoc.xml · nonDerivative · entry 2 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886 F1 · kind: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| August 31, 2022 Filed Sep 3, 2022 01:06 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionCommon Stock | 183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-021841 · rdgdoc.xml · nonDerivative · entry 1 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On August 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $462.30 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:52 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018666 · rdgdoc.xml · derivative · entry 3 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. F1 · derivative.exercise_date: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. F1 · derivative.expiration_date: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:52 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Stock | 121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-018666 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 F1 · kind: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. F1 · price: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:52 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-018666 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022. Read SEC document |
| June 07, 2022 Filed Aug 26, 2022 22:08 UTC |
JAEGER RAVENChief Regulatory Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $7.75 | $0.00 |
DisclosureSEC source: 0001437749-22-021414 · rdgdoc.xml · derivative · entry 1 JAEGER RAVEN · CIK 0001944263 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning June 30, 2022. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 00:37 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-014181 · rdgdoc.xml · derivative · entry 3 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915 Underlying: Common Stock · 183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 00:37 UTC |
Hollingsworth Jane HDirector
|
Disposition to issuerCommon Stock | 67 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014181 · rdgdoc.xml · nonDerivative · entry 2 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 00:37 UTC |
Hollingsworth Jane HDirector
|
Exercise / conversionCommon Stock | 183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014181 · rdgdoc.xml · nonDerivative · entry 1 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 116 Shares and (ii) $550.07 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $8.21. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:24 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-010718 · rdgdoc.xml · derivative · entry 3 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:24 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Sock | 121 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-010718 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998 F1 · kind: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:24 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-010718 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 2, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:18 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
ConversionSeries C Convertible Preferred Stock · Derivative | 100 | $25.00 Strike: $25.00 | $2,500.00 |
DisclosureSEC source: 0001437749-22-009234 · rdgdoc.xml · derivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · derivative.exercise_price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F1 · derivative.exercise_date: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F1 · derivative.expiration_date: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · derivative.underlying_shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · balance_after: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:18 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
ConversionCommon Stock | 100 | $25.00 | $2,500.00 |
DisclosureSEC source: 0001437749-22-009234 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F1 · price: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · balance_after: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:17 UTC |
ELDER WILLIAM ROBERTGC & Secretary
|
ConversionSeries C Convertible Preferred Stock · Derivative | 100 | $25.00 Strike: $25.00 | $2,500.00 |
DisclosureSEC source: 0001437749-22-009233 · rdgdoc.xml · derivative · entry 2 ELDER WILLIAM ROBERT · CIK 0001828068 · GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · derivative.exercise_price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F1 · derivative.exercise_date: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F1 · derivative.expiration_date: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · derivative.underlying_shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · balance_after: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:17 UTC |
ELDER WILLIAM ROBERTGC & Secretary
|
ConversionCommon Stock | 100 | $25.00 | $2,500.00 |
DisclosureSEC source: 0001437749-22-009233 · rdgdoc.xml · nonDerivative · entry 1 ELDER WILLIAM ROBERT · CIK 0001828068 · GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · shares: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F1 · price: As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Series C Shares"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement. On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the "Certificate of Designation"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation. F2 · price: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. F2 · balance_after: All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 11:30 UTC |
ELDER WILLIAM ROBERTGC & Secretary
|
PurchaseSeries C Convertible Preferred Stock · Derivative | 5,000 | $0.50 Strike: $0.50 | $2,500.00 |
DisclosureSEC source: 0001437749-22-006872 · rdgdoc.xml · derivative · entry 1 ELDER WILLIAM ROBERT · CIK 0001828068 · GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · security: 1. On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. F1 · derivative.exercise_date: 1. On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. F1 · derivative.expiration_date: 1. On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 11:30 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
PurchaseSeries C Convertible Preferred Stock · Derivative | 5,000 | $0.50 Strike: $0.50 | $2,500.00 |
DisclosureSEC source: 0001437749-22-006871 · rdgdoc.xml · derivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · security: On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. F1 · derivative.exercise_date: On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. F1 · derivative.expiration_date: On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:18 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-002262 · rdgdoc.xml · derivative · entry 3 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,400 Underlying: Common Stock · 16,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:18 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Stock | 6,049 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-002262 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,602 F1 · kind: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:18 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 16,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-002262 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 11:08 UTC |
Hornung William KarlChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 305,743 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-22-001917 · rdgdoc.xml · derivative · entry 1 Hornung William Karl · CIK 0001612066 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,743 Underlying: Common Stock · 305,743 shares Expires 2032-01-27 F1 · derivative.exercise_date: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 11:06 UTC |
GALLOWAY CHRISTOPHER DChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 305,743 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-22-001915 · rdgdoc.xml · derivative · entry 1 GALLOWAY CHRISTOPHER D · CIK 0001829319 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,743 Underlying: Common Stock · 305,743 shares Expires 2032-01-27 F1 · derivative.exercise_date: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 11:04 UTC |
ELDER WILLIAM ROBERTGC & Secretary
|
GrantStock Option (Right to Buy) · Derivative | 305,743 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-22-001913 · rdgdoc.xml · derivative · entry 1 ELDER WILLIAM ROBERT · CIK 0001828068 · GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,743 Underlying: Common Stock · 305,743 shares Expires 2032-01-27 F1 · derivative.exercise_date: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 11:02 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 764,357 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-22-001911 · rdgdoc.xml · derivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764,357 Underlying: Common Stock · 764,357 shares Expires 2032-01-27 F1 · derivative.exercise_date: The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022. Read SEC document |
| November 01, 2021 Filed Nov 4, 2021 01:07 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 16,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-025138 · rdgdoc.xml · derivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,750 Underlying: Common Stock · 16,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. F1 · derivative.exercise_date: On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. F1 · derivative.expiration_date: On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. Read SEC document |
| November 01, 2021 Filed Nov 4, 2021 01:07 UTC |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 16,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-025138 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments. Read SEC document |
| November 01, 2021 Filed Feb 3, 2022 01:18 UTC Amendment |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-002263 · rdgdoc.xml · derivative · entry 3 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,750 Underlying: Common Stock · 16,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.exercise_date: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · derivative.expiration_date: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 01, 2021 Filed Feb 3, 2022 01:18 UTC Amendment |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Disposition to issuerCommon Stock | 6,049 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-002263 · rdgdoc.xml · nonDerivative · entry 2 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,301 F1 · kind: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. F1 · price: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| November 01, 2021 Filed Feb 3, 2022 01:18 UTC Amendment |
Cobuzzi Robert Joseph Jr.Director · President & CEO
|
Exercise / conversionCommon Stock | 16,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-002263 · rdgdoc.xml · nonDerivative · entry 1 Cobuzzi Robert Joseph Jr. · CIK 0001799838 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:42 UTC |
Hollingsworth Jane HDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016512 · rdgdoc.xml · derivative · entry 1 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:42 UTC |
LEVIN ALAN GDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016511 · rdgdoc.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC |
Adams Robert WDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016510 · rdgdoc.xml · derivative · entry 1 Adams Robert W · CIK 0001663144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC |
Francois EricDirector
|
GrantRestricted Stock Unit · Derivative | 69,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-016509 · rdgdoc.xml · derivative · entry 3 Francois Eric · CIK 0001656125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,400 Underlying: Common Stock · 69,400 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023. F4 · derivative.expiration_date: The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC |
Francois EricDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016509 · rdgdoc.xml · derivative · entry 2 Francois Eric · CIK 0001656125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F2 · derivative.exercise_date: The shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC |
Francois EricDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016509 · rdgdoc.xml · derivative · entry 1 Francois Eric · CIK 0001656125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:41 UTC |
Giles Mark TDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-016508 · rdgdoc.xml · derivative · entry 1 Giles Mark T · CIK 0001663219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Oct 16, 2021 00:01 UTC |
LANCHONEY DIANA MDirector
|
GrantRestricted Stock Unit · Derivative | 69,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-023770 · rdgdoc.xml · derivative · entry 3 LANCHONEY DIANA M · CIK 0001887450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,400 Underlying: Common Stock · 69,400 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023. F4 · derivative.expiration_date: The shares underlying the restricted stock units will vest in 6 equal (or as nearly equal as possible) tri-monthly installments on the last calendar day of every third month over an 18-month period beginning on January 1, 2023. Read SEC document |
| July 01, 2021 Filed Oct 16, 2021 00:01 UTC |
LANCHONEY DIANA MDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-023770 · rdgdoc.xml · derivative · entry 2 LANCHONEY DIANA M · CIK 0001887450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F2 · derivative.exercise_date: The shares underlying the options will vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning July 1, 2021. Read SEC document |
| July 01, 2021 Filed Oct 16, 2021 00:01 UTC |
LANCHONEY DIANA MDirector
|
GrantStock Option (Right to Buy) · Derivative | 83,300 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001437749-21-023770 · rdgdoc.xml · derivative · entry 1 LANCHONEY DIANA M · CIK 0001887450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Underlying: Common Stock · 83,300 shares Expires 2031-07-01 F1 · derivative.exercise_date: The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:27 UTC |
Hollingsworth Jane HDirector
|
PurchaseCommon Stock | 32,786 | $0.61 | $19,999.46 |
DisclosureSEC source: 0001437749-21-012537 · rdgdoc.xml · nonDerivative · entry 1 Hollingsworth Jane H · CIK 0001297141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,786 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6097 to $0.6141, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.